Fig. 4.
Fig. 4. Proliferative index of the expanded TCRVβsubsets. / The proliferative index measured by the percentage of cells within S phase of expanded TCRVβ+ T cells in MM patients (far left column) and compared with that of the total CD8+ or total CD4+ T cells in MM patients (second and third columns from left) and normal controls (NCs, fourth and fifth columns from left). No significant difference was found among the groups (one-way analysis of variance [ANOVA],P = .84). The positive control was cultured CD8+ cells of patient D at 24 hours after stimulation with various amounts of phytohemagglutinin (PHA). *Far right column, shown as squares in order from top to bottom with the following amounts of PHA added to the 1-mL culture medium: 15 μg, 11.1%; 5 μg, 5.3%; 1.5 μg, 3.7%, and 0 μg, 1.6%.

Proliferative index of the expanded TCRVβsubsets.

The proliferative index measured by the percentage of cells within S phase of expanded TCRVβ+ T cells in MM patients (far left column) and compared with that of the total CD8+ or total CD4+ T cells in MM patients (second and third columns from left) and normal controls (NCs, fourth and fifth columns from left). No significant difference was found among the groups (one-way analysis of variance [ANOVA],P = .84). The positive control was cultured CD8+ cells of patient D at 24 hours after stimulation with various amounts of phytohemagglutinin (PHA). *Far right column, shown as squares in order from top to bottom with the following amounts of PHA added to the 1-mL culture medium: 15 μg, 11.1%; 5 μg, 5.3%; 1.5 μg, 3.7%, and 0 μg, 1.6%.

Close Modal

or Create an Account

Close Modal
Close Modal